Aris N Economides

This inventor holds 53 USPTO granted patents and 14 published patent applications, plus 9 CIPO patents and 18 EPO patents, primarily in Genetic Engineering (CPC class C07K). Top assignees: Regeneron Pharmaceuticals, Inc., Cornell University, Regeneran Pharmaceuticals, Inc.. Active years: 1995-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aris N Economides. Retrieved from https://idiyas.com/inventor/aris-n-economides

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 53 (Patent Applications = 14)

% Patents Active = 60.4

CIPO Patents = 9 (Patent Applications = 8)

EPO Patents = 18 (Patent Applications = 26)

Average Co-Inventor Count = 3.8

ph-index = 9

Forward Citations = 606(Granted Patents)

Forward Citations (Not Self Cited) = 511(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Dobbs Ferry, NY (US) (1998)
New York, NY (US) (1995 - 2007)
Tarrytown, NY (US) (2003 - 2024)

Company Filing History:

51 out of 1,482

Regeneron Pharmaceuticals, Inc.

Regeneran Pharmaceuticals, Inc.

patents

4. 1 out of 16,035

University of California

patents

5. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...

Areas of Expertise:

Genome Modification

Hybrid Antibodies

ACVR1 Gene

Nucleic Acids

Eukaryotic Cells

Fibrodysplasia Ossificans Progressiva

Conditional Mutants

Progeroid Syndrome

Immunoglobulin Locus

Homologous Recombination

Multispecific Antibodies

Mouse Embryonic Stem Cells

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473574 - Methods for modifying a genome (2025-11-18),

2. 12089576 - Nucleic acids comprising a modified rodent activin a receptor type 1 (Acvr1) gene (2024-09-17),

3. 11945872 - Anti-ACVR1 antibodies and uses thereof (2024-04-02),

4. 11730150 - Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy (2023-08-22),

5. 11634480 - Human antibodies to GREM1 (2023-04-25),

6. 11578135 - Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof (2023-02-14),

7. 11419319 - Genetically modified rodent with an inducible ACVR1 mutation in exon 7 that causes ectopic bone formation (2022-08-23),

8. 11407822 - Treatment of fibrodysplasia ossificans progressiva (2022-08-09),

9. RE49121 - Genetically modified mouse with an inducible ACVR1 gene with a mutant R206H exon 5 that has ectopic bone formation (2022-07-04),

10. 11319557 - Multifunctional alleles (2022-05-03),

11. 10988776 - Methods of modifying genes in eukaryotic cells (2021-04-27),

12. 10640800 - Mice that produce hybrid antibodies (2020-05-05),

13. 10584364 - Mice that produce hybrid antibodies (2020-03-10),

14. 10548302 - Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy (2020-02-04),

15. 10531648 - Conditional rodent Acvr1 mutant gene (2020-01-14),

Title: The Innovative Journey of Aris N Economides

Introduction:

Aris N Economides, a talented inventor based in Tarrytown, NY, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Economides holds several patents in various technological domains, including advancements in artificial intelligence, renewable energy, and medical devices. His latest patents focus on enhancing user experience in virtual reality applications.

Career Highlights:

With a career spanning over two decades, Aris N Economides has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on improving efficiency and effectiveness in different industries.

Collaborations:

Throughout his career, Economides has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful commercialization of several groundbreaking technologies.

Conclusion:

In conclusion, Aris N Economides continues to push the boundaries of innovation with his creative thinking and passion for problem-solving. His dedication to creating solutions that make a difference in people's lives sets him apart as a true pioneer in the world of technology.

Profile summary based on public USPTO records.